Use of CXCL9 as a Biomarker of Acthar Efficacy
Clinical trial NCT02523092 · TERMINATED
Trial details
- NCT number
- NCT02523092
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-03
- Primary completion
- 2025-01-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.